Veterinary Medicines

Equilis StrepE (--) - Lyophilisate and solvent for suspension for injection

Authorised
  • Streptococcus equi subsp. equi, strain TW928, Live
Download as PDF

Product identification

Medicine name:
Equilis StrepE (--) - Lyophilisate and solvent for suspension for injection
Active substance:
  • Streptococcus equi subsp. equi, strain TW928, Live
Target species:
  • Horse
Route of administration:
  • Submucosal use

Product details

Active substance and strength:
  • Streptococcus equi subsp. equi, strain TW928, Live
    Presentation_strength:10⁹·⁰ to 10⁹·⁴ CFU Reference:HSE Index:0
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Submucosal use
    • Horse
      • Not applicable
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI05AE
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
Available in:
  • Belgium
  • France
  • Netherlands
Package description:
  • Packaging:Lyophilisate: vial (glass); solvent: vial (glass), Package_size:10 vials lyophilisate, 10 vials solvent, 10 applicators, 10 syringes with needle, Content:Powder: 1 dose; solvent 0.5 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Council Directive 81/851/EEC
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • European Commission
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

English (PDF)
Published on: 9/11/2022
Download
Bulgarian (PDF)
Published on: 9/11/2022
Download
Croatian (PDF)
Published on: 9/11/2022
Download
Czech (PDF)
Published on: 9/11/2022
Download
Danish (PDF)
Published on: 9/11/2022
Download
Dutch (PDF)
Published on: 9/11/2022
Download
Estonian (PDF)
Published on: 9/11/2022
Download
Finnish (PDF)
Published on: 9/11/2022
Download
French (PDF)
Published on: 9/11/2022
Download
German (PDF)
Published on: 9/11/2022
Download
Greek (PDF)
Published on: 9/11/2022
Download
Hungarian (PDF)
Published on: 9/11/2022
Download
Icelandic (PDF)
Published on: 9/11/2022
Download
Italian (PDF)
Published on: 9/11/2022
Download
Latvian (PDF)
Published on: 9/11/2022
Download
Lithuanian (PDF)
Published on: 9/11/2022
Download
Maltese (PDF)
Published on: 9/11/2022
Download
Norwegian (PDF)
Published on: 9/11/2022
Download
Polish (PDF)
Published on: 9/11/2022
Download
Portuguese (PDF)
Published on: 9/11/2022
Download
Romanian (PDF)
Published on: 9/11/2022
Download
Slovak (PDF)
Published on: 9/11/2022
Download
Slovenian (PDF)
Published on: 9/11/2022
Download
Spanish (PDF)
Published on: 9/11/2022
Download
Swedish (PDF)
Published on: 9/11/2022
Download

ema-puar-equilis-strepe-v-078-par-en.pdf

English (PDF)
Published on: 14/03/2023
Download